TAMOXIFEN CITRATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tamoxifen Citrate, and when can generic versions of Tamoxifen Citrate launch?
Tamoxifen Citrate is a drug marketed by Actavis Labs Fl Inc, Aegis Pharms, Apotex, Dr Reddys Labs Sa, Eugia Pharma, Ivax Sub Teva Pharms, Mylan, Pharmachemie, Roxane, Teva, and Zydus Pharms. and is included in twelve NDAs.
The generic ingredient in TAMOXIFEN CITRATE is tamoxifen citrate. There are sixteen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the tamoxifen citrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tamoxifen Citrate
A generic version of TAMOXIFEN CITRATE was approved as tamoxifen citrate by ACTAVIS LABS FL INC on February 20th, 2003.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TAMOXIFEN CITRATE?
- What are the global sales for TAMOXIFEN CITRATE?
- What is Average Wholesale Price for TAMOXIFEN CITRATE?
Summary for TAMOXIFEN CITRATE
| US Patents: | 0 |
| Applicants: | 11 |
| NDAs: | 12 |
| Finished Product Suppliers / Packagers: | 13 |
| Raw Ingredient (Bulk) Api Vendors: | 93 |
| Clinical Trials: | 125 |
| Patent Applications: | 8,354 |
| Drug Prices: | Drug price information for TAMOXIFEN CITRATE |
| DailyMed Link: | TAMOXIFEN CITRATE at DailyMed |
See drug prices for TAMOXIFEN CITRATE
Recent Clinical Trials for TAMOXIFEN CITRATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Sharif Medical Research Center | Phase 2 |
| Baylor College of Medicine | Early Phase 1 |
| Great Ormond Street Hospital Charity | Phase 1/Phase 2 |
Pharmacology for TAMOXIFEN CITRATE
| Drug Class | Estrogen Agonist/Antagonist |
| Mechanism of Action | Selective Estrogen Receptor Modulators |
Medical Subject Heading (MeSH) Categories for TAMOXIFEN CITRATE
Anatomical Therapeutic Chemical (ATC) Classes for TAMOXIFEN CITRATE
US Patents and Regulatory Information for TAMOXIFEN CITRATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Labs Fl Inc | TAMOXIFEN CITRATE | tamoxifen citrate | TABLET;ORAL | 070929-001 | Feb 20, 2003 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Roxane | TAMOXIFEN CITRATE | tamoxifen citrate | TABLET;ORAL | 076027-001 | Feb 20, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Apotex | TAMOXIFEN CITRATE | tamoxifen citrate | TABLET;ORAL | 090878-001 | Sep 23, 2011 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
